Evidence map›Paper›PMID 8801203›Full record

ArticleGut1996

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.

C Penna, R Dozois, W Tremaine, W Sandborn, N LaRusso, C Schleck, D Ilstrup

4 registry-linked trialsOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Gut, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 100 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 7 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00583076 phase2completednot on this mapstarted 2007, after this paper: background citation

A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis

TypeinterventionalSponsorOcera TherapeuticsRan2007 to 2008Enrolled19ConditionsPouchitisArmsAST-120
NCT00583531 phase2terminatednot on this mapstarted 2007, after this paper: background citation

A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis

TypeinterventionalSponsorOcera TherapeuticsRan2007 to 2008Enrolled2ConditionsPouchitisArmsAST-120
NCT02438410 completednot on this mapstarted 2015, after this paper: background citation

Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis

TypeobservationalSponsorMayo ClinicRan2015 to 2019Enrolled13ConditionsColitis, Ulcerative, Inflammatory Bowel Disease, IBD
NCT06312683 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Rifaximin for the Secondary Prevention of Recurrent Pouchitis

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2024 to 2027Enrolled16ConditionsPouchitisArmsRifaximin 550 MG Oral Tablet [XIFAXAN]
3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 7 syntheses or guidelines pooled it, 572 citations in OpenAlex.

  1. [Living guideline on ulcerative colitis].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2022
    Guideline
  2. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.Deutsches Arzteblatt international · 2020
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Use of Biologics in Pouchitis: A Systematic Review.Journal of clinical gastroenterology · 2015
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Recurrent Pouchitis Uncovering De Novo Celiac Disease.Case reports in gastrointestinal medicine · 2025
    Article
  13. [Postoperative Imaging Findings of Colorectal Surgery: A Pictorial Essay].Journal of the Korean Society of Radiology · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

C PennaDivision of Colon and Rectal Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
R Dozois
W Tremaine
W Sandborn
N LaRusso
C Schleck
D Ilstrup
Mayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary sclerosing cholangitis (PSC), present in 5% of patients with ulcerative colitis, may be associated with pouchitis after ileal pouch-anal anastomosis. The cumulative frequency of pouchitis in patients with and without PSC who underwent ileal pouch-anal anastomosis for ulcerative colitis was determined. A total of 1097 patients who had an ileal pouch-anal anastomosis for ulcerative colitis, 54 with associated PSC, were studied. Pouchitis was defined by clinical criteria in all patients and by clinical, endoscopic, and histological criteria in 83% of PSC patients and 85% of their matched controls. PSC was defined by clinical, radiological, and pathological findings. One or more episodes of pouchitis occurred in 32% of patients without PSC and 63% of patients with PSC. The cumulative risk of pouchitis at one, two, five, and 10 years after ileal pouch-anal anastomosis was 15.5%, 22.5%, 36%, and 45.5% for the patients without PSC and 22%, 43%, 61%, and 79% for the patients with PSC. In the PSC group, the risk of pouchitis was not related to the severity of liver disease. In conclusion, the strong correlation between PSC and pouchitis suggest a common link in their pathogenesis.

Indexed as

AdolescentAdultAnal CanalAnastomosis, SurgicalCholangitis, SclerosingColitis, UlcerativeFemaleFollow-Up StudiesHumansIleitisMaleMiddle AgedPostoperative ComplicationsProctocolectomy, RestorativeRisk Factors

Identifiers

PMID8801203
PMCPMC1383029
OpenAlexW2028875662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.